465 related articles for article (PubMed ID: 23369227)
1. Serum irisin levels in new-onset type 2 diabetes.
Choi YK; Kim MK; Bae KH; Seo HA; Jeong JY; Lee WK; Kim JG; Lee IK; Park KG
Diabetes Res Clin Pract; 2013 Apr; 100(1):96-101. PubMed ID: 23369227
[TBL] [Abstract][Full Text] [Related]
2. Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes.
Liu J; Hu Y; Zhang H; Xu Y; Wang G
J Diabetes Complications; 2016; 30(8):1555-1559. PubMed ID: 27503404
[TBL] [Abstract][Full Text] [Related]
3. Irisin in the Glucose Continuum.
Assyov Y; Gateva A; Tsakova A; Kamenov Z
Exp Clin Endocrinol Diabetes; 2016 Jan; 124(1):22-7. PubMed ID: 26479549
[TBL] [Abstract][Full Text] [Related]
4. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
5. Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus.
Elizondo-Montemayor L; Gonzalez-Gil AM; Tamez-Rivera O; Toledo-Salinas C; Peschard-Franco M; Rodríguez-Gutiérrez NA; Silva-Platas C; Garcia-Rivas G
Mediators Inflamm; 2019; 2019():6737318. PubMed ID: 31015797
[TBL] [Abstract][Full Text] [Related]
6. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy.
Xiang L; Xiang G; Yue L; Zhang J; Zhao L
Atherosclerosis; 2014 Aug; 235(2):328-33. PubMed ID: 24911636
[TBL] [Abstract][Full Text] [Related]
7. The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: a preliminary study.
Zhang M; Chen P; Chen S; Sun Q; Zeng QC; Chen JY; Liu YX; Cao XH; Ren M; Wang JK
Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1567-72. PubMed ID: 24943964
[TBL] [Abstract][Full Text] [Related]
8. Irisin levels in the progression of diabetes in sedentary women.
Duran ID; Gülçelik NE; Ünal M; Topçuoğlu C; Sezer S; Tuna MM; Berker D; Güler S
Clin Biochem; 2015 Dec; 48(18):1268-72. PubMed ID: 26234637
[TBL] [Abstract][Full Text] [Related]
9. Association between irisin and homocysteine in euglycemic and diabetic subjects.
Alis R; Sanchis-Gomar F; Pareja-Galeano H; Hernández-Mijares A; Romagnoli M; Víctor VM; Rocha M
Clin Biochem; 2014 Dec; 47(18):333-5. PubMed ID: 25192692
[TBL] [Abstract][Full Text] [Related]
10. The association between serum irisin levels and cardiovascular disease in diabetic patients.
Khorasani ZM; Bagheri RK; Yaghoubi MA; Chobkar S; Aghaee MA; Abbaszadegan MR; Sahebkar A
Diabetes Metab Syndr; 2019; 13(1):786-790. PubMed ID: 30641808
[TBL] [Abstract][Full Text] [Related]
11. Lower circulating irisin is associated with type 2 diabetes mellitus.
Liu JJ; Wong MD; Toy WC; Tan CS; Liu S; Ng XW; Tavintharan S; Sum CF; Lim SC
J Diabetes Complications; 2013; 27(4):365-9. PubMed ID: 23619195
[TBL] [Abstract][Full Text] [Related]
12. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.
Tang L; Tong Y; Zhang F; Chen G; Zhang YC; Jobin J; Tong N
BMC Endocr Disord; 2019 Dec; 19(1):147. PubMed ID: 31881940
[TBL] [Abstract][Full Text] [Related]
13. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study.
Sahin-Efe A; Upadhyay J; Ko BJ; Dincer F; Park KH; Migdal A; Vokonas P; Mantzoros C
Metabolism; 2018 Feb; 79():24-32. PubMed ID: 29108900
[TBL] [Abstract][Full Text] [Related]
14. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents.
Jang HB; Kim HJ; Kang JH; Park SI; Park KH; Lee HJ
Metabolism; 2017 Aug; 73():100-108. PubMed ID: 28732566
[TBL] [Abstract][Full Text] [Related]
15. Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics.
Provatopoulou X; Georgiou GP; Kalogera E; Kalles V; Matiatou MA; Papapanagiotou I; Sagkriotis A; Zografos GC; Gounaris A
BMC Cancer; 2015 Nov; 15():898. PubMed ID: 26560078
[TBL] [Abstract][Full Text] [Related]
16. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans.
Choi HY; Kim S; Park JW; Lee NS; Hwang SY; Huh JY; Hong HC; Yoo HJ; Baik SH; Youn BS; Mantzoros CS; Choi KM
J Clin Endocrinol Metab; 2014 Aug; 99(8):2778-85. PubMed ID: 24780049
[TBL] [Abstract][Full Text] [Related]
17. The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype.
Hwang YC; Jeon WS; Park CY; Youn BS
Cardiovasc Diabetol; 2016 Jan; 15():9. PubMed ID: 26790404
[TBL] [Abstract][Full Text] [Related]
18. Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus.
El-Lebedy DH; Ibrahim AA; Ashmawy IO
Diabetes Metab Syndr; 2018 Sep; 12(5):643-648. PubMed ID: 29673927
[TBL] [Abstract][Full Text] [Related]
19. Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels.
Rana KS; Pararasa C; Afzal I; Nagel DA; Hill EJ; Bailey CJ; Griffiths HR; Kyrou I; Randeva HS; Bellary S; Brown JE
Cardiovasc Diabetol; 2017 Nov; 16(1):147. PubMed ID: 29121940
[TBL] [Abstract][Full Text] [Related]
20. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans.
Norheim F; Langleite TM; Hjorth M; Holen T; Kielland A; Stadheim HK; Gulseth HL; Birkeland KI; Jensen J; Drevon CA
FEBS J; 2014 Feb; 281(3):739-49. PubMed ID: 24237962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
